“Bringing IPS into Carilion Labs will enhance our ability to provide our patients with the highest quality pathology and cytology services”, said Bud Thompson, CEO of Carilion Labs. “In addition, current IPS customers will now have access to a full range of laboratory services from one convenient source.”
“IPS and Carilion Labs share a commitment to quality, service and innovation”, said Stephen Swanger, MD, Medical Director for IPS Anatomic Pathology Laboratory. “Joining with Carilion Labs will help us grow to meet our patient’s needs, while maintaining the independence that sets IPS apart from other providers.”
Both Carilion Labs and IPS are committed to a seamless transition for patients, who will benefit from a broader range of services from a single source.